Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albigès, Fabrice Barlési, Stéphanie Foulon et al.|Nature Cancer|2020Cited by 119
Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Marie Sébert, Lise Larcher et al.|Blood|2022Cited by 80
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Claude Preudhomme, Loïc Vasseur et al.|Leukemia|2023Cited by 30
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 TrialRathana Kim, Emmanuelle Clappier, Philippe Rousselot et al.|Blood|2021Cited by 9